Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature

Am J Clin Dermatol. 2020 Apr;21(2):303-305. doi: 10.1007/s40257-020-00511-5.

Authors

Ruth A Barker¹, Christopher Wilcox², Alison M Layton^{3

4}

Affiliations

¹ Hull York Medical School, Allam Medical Building, University of Hull, Hull, HU6 7RX, UK. hyrb14@hyms.ac.uk.
² Department of Primary Care and Population Sciences, Aldermoor Health Center, University of Southampton, Southampton, UK.
³ Hull York Medical School, Allam Medical Building, University of Hull, Hull, HU6 7RX, UK.
⁴ Department of Dermatology, Harrogate and District NHS Foundation Trust, Harrogate, UK.

PMID: 32166709
DOI: 10.1007/s40257-020-00511-5

No abstract available

Publication types

Letter
Review

MeSH terms

Acne Vulgaris / drug therapy*
Administration, Oral
Adult
Clinical Trials as Topic
Female
Humans
Mineralocorticoid Receptor Antagonists / administration & dosage*
Spironolactone / administration & dosage*
Treatment Outcome

Substances

Mineralocorticoid Receptor Antagonists
Spironolactone